About Taho Pharma
Taho Pharma is a company based in Taipei (Taiwan) founded in 2010.. Taho Pharma operates in a competitive market with competitors including Biogen, GSK, Denali Therapeutics, Avidity Biosciences and Annexon, among others.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Taho Pharmaceuticals Ltd
-
Annual Revenue
$0 (USD)-100as on Dec 31, 2024
-
Net Profit
$0 (USD)-38.74as on Dec 31, 2024
-
EBITDA
$0 (USD)-43.92as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Taho Pharma
Taho Pharma is a publicly listed company on the TPEX with ticker symbol 6467 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Taho Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Taho Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Taho Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Taho Pharma Comparisons
Competitors of Taho Pharma
Taho Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, GSK, Denali Therapeutics, Avidity Biosciences and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Taho Pharma
Frequently Asked Questions about Taho Pharma
When was Taho Pharma founded?
Taho Pharma was founded in 2010.
Where is Taho Pharma located?
Taho Pharma is headquartered in Taipei, Taiwan.
What does Taho Pharma do?
Taho Pharma is a speciality pharma company developing novel CNS and oncology drugs through their proprietary drug delivery platform. The companys transdermal delivery system allows the active ingredient is absorbed by the skin and distributed through the bloodstream and have capabilities for long-term controlled release and consistent plasma concentration. Their transmucosal drug delivery system which delivers drugs through orally dissolving films (ODFs), can facilitate faster onset and may avoid the first-pass effect, and can be formulated for both immediate (oralsublingual) and controlled release (buccalgum) delivery forms. The company has developed transdermal patches for Alzheimers, Schizophrenia, and epilepsy and an oral solution for ADHD and anti-emetic OD films for oncology support.
Who are the top competitors of Taho Pharma?
Taho Pharma's top competitors include Entrada Therapeutics, Sutro Biopharma and Synthego.
Is Taho Pharma publicly traded?
Yes, Taho Pharma is publicly traded on TPEX under the ticker symbol 6467.
What is Taho Pharma's ticker symbol?
The ticker symbol of Taho Pharma is 6467 on TPEX.